Good portfolio - Avis employé Employé (anonyme) BeOne
4,0
3 sept. 2021
Employé (anonyme)
Employé (ancien), plus de 10 an(s)
Recommande
Approbation du PDG
Perspective commerciale
Avantages
Good molecules but all followers not FIC or BIC
Inconvénients
Communication gaps between US team and China team
Découvrez plus d’avis sur BeOne
5,0
24 avr. 2026
Employé (anonyme)
Employé (actuel)
Recommande
Approbation du PDG
Perspective commerciale
Avantages
BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.
Inconvénients
Fast timelines and global expansion may translate into heavy workload and urgency